Decoding common and complex genotypes of facioscapulohumeral muscular dystrophy using methylation profiling and long-read sequencing

Clicks: 2
ID: 332061
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #162 of 162 articles by views in Brain communications

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 162 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Abstract Due to the complexity of the genomic region, the relationship between genotype, phenotype, and epigenetics in facioscapulohumeral muscular dystrophy remains incompletely understood, and diagnostics limited in precision. In this study, we applied Oxford Nanopore Technology long-read sequencing to characterize FSHD1 and FSHD2 patients with common and previously confirmed genotypes (n = 14). This approach enabled the simultaneous determination of allele-specific methylation profiles, haplotype, and repeat length. Our results confirm the presence of an asymmetric methylation gradient increasing from the proximal to distal end of 4q35 repeat arrays with a steeper slope in FSHD1 (2.5–8.1%/repeat unit) compared to the two FSHD2 patients (0.3 and 1.2%/repeat unit) studied. The slope is therefore a potential marker to differentiate both types of facioscapulohumeral muscular dystrophy, being less biased by repeat length compared to parameters determined in current bisulfite sequencing-based methylation assays. By determining distal methylation allele-specifically long-read sequencing overcomes a major limitation of such assays. Distal methylation of pathogenic (range 22–45%) and non-pathogenic repeat arrays (range 77–87%) (P < 0.0001) is clearly separated and shows a stronger correlation with age-corrected clinical severity (r = -0.81, 95%-CI: -0.48–-0.94) compared to studies based on bisulfite sequencing. Overall, this strengthens distal methylation as a superior diagnostic marker of facioscapulohumeral muscular dystrophy disease status. Detailed clinical and genetic characterization of a second cohort (n = 20) comprising patients with complex genotypes (n = 11) and FSHD2 (n = 9) was performed using our bisulfite sequencing-based methylation profile analysis, complementary methods, and in three cases, long-read sequencing. Based on these results we highlight underrecognized patient groups at risk of misdiagnosis when methylation analysis is not part of the diagnostic workup: i) patients carrying a 4qA166 repeat array, ii) patients with underrepresented population backgrounds, iii) facioscapulohumeral muscular dystrophy patients carrying 11 repeat units in the absence of global hypomethylation, and iv) FSHD2 patients without a detectable causative variant in known epigenetic suppressor genes (SMCHD1, DNMT3B, and LRIF1). We hypothesize that unknown epigenetic modifiers explain the penetrance of repeat arrays with 8–10 repeat units in the European and North American population, the pathogenicity of some repeat arrays with 11 repeat units, and the hypomethylation of the entire 4q35 repeat array in some FSHD2 patients without a detected variant in known epigenetic suppressor genes. From our results recommendations for standard diagnostics are derived. Finally, we hypothesize a preliminary model linking DNA methylation, known genetic parameters and disease severity.
Reference Key
openalex_W7221357826 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Florentine Scharf, Morghan C. Lucas, Stefanie Gehling, Felix Kleefeld, Veronika Schönrock, Anna Benet‐Pagès, Hans-Werner Rausch, Lucas Schirmer, Jochen Schäfer, Annika Saak, Joseph Porrmann, Sylvia Hütter, Christina Emde, Anne Boblest, Svenja Neuhoff, Tim Hagenacker, Sebastian Burkart, Sebastian Mingers, Ann-Cathrine Berking, Lisa Isabel Olfe, Corinna Hendrich, Kristin Schröck, Elizabeta Sauer, Agata A. Mossakowski, Kai Sendelbach, Udo Koehler, Kerstin Becker, Tobias Bartolomaeus, Ariane Hallermayr, Barbara Klink, Teresa Neuhann, Maggie Christine Walter, Benedikt G. H. Schoser, Angela Abicht, Hannes Erdmann
Journal Brain communications
Year 2026
DOI
10.1093/braincomms/fcag370
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.